ESC 365 - NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?

ESC Premium Access

NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?

Session: Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

Topic: Noncoronary Cardiac Intervention

Speaker: Professor J. Mehilli (Landshut, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Julinda Mehilli

Hospital Landshut-Achdorf, Landshut (Germany)

31 presentations

20 followers

2 more presentations in this session

What is the latest randomized evidence in TAVI field.

Speaker: Professor A. Baumbach (London, GB)

Is durability still an issue?

Speaker: Professor E. Durand (Rouen, FR)

Access the full session

Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

Speakers: Professor J. Mehilli, Professor A. Baumbach, Professor E. Durand

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources